Skip to content

Insider · CIK 0001405288

Jacqualyn A Fouse

director

Files at INCY (INCYTE CORP), MDGL (MADRIGAL PHARMACEUTICALS, INC.), AGIO (AGIOS PHARMACEUTICALS, INC.). First filing Apr 10, 2025, latest Apr 10, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $194k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AGIO: AGIOS PHARMACEUTICALS, INC.

AGIOOct 9, 2026 · close 31.81

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
0Weak
AGIOsell10b5-1
AGIOS PHARMACEUTICALS, INC.
$194k
7,497 shares
-5%+3% from low-59% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 20, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+203$0.00$01,097Jun 24, 2025
Jun 20, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+366$0.00$0366Jun 24, 2025
Jun 20, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock
+2,120$0.00$0151,340Jun 23, 2025
Jun 18, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AGrant or award
Restricted stock unitsderivative
+2,816$0.00$02,816Jun 23, 2025
Jun 18, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AGrant or award
Stock options (right to buy)derivative
+15,768$0.00$015,768Jun 23, 2025
Jun 20, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Restricted stock unitsderivative
-2,120$0.00$00Jun 23, 2025
Jun 10, 2025INCY
INCYTE CORP
AGrant or award
Common Stock
+2,518$0.00$019,326Jun 12, 2025
Jun 10, 2025INCY
INCYTE CORP
AGrant or award
Non Qualfied Stock Option (right to buy)derivative
+9,216$0.00$09,216Jun 12, 2025
Apr 8, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Common stock10b5-1
+15,933$0.00$0156,717Apr 10, 2025
Apr 10, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SOpen-market sale
Common stock10b5-1
-7,497$25.90$194k149,220Apr 10, 2025
Apr 8, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
MOption exercise
Restricted stock unitsderivative10b5-1
-15,933$0.00$00Apr 10, 2025
Mar 10, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+894$0.00$0894Mar 12, 2025
Mar 10, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+1,579$0.00$01,579Mar 12, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jacqualyn A Fouse: insider trades and track record | InsiderTell